Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma: A definitive anal sphincter-preserving radiotherapy

This study evaluated the 4-year results of 32 patients with T1N0 low-lying rectal adenocarcinoma treated solely with californium-252 (Cf-252) neutron intracavity brachytherapy (ICBT). Patients were solicited into the study from January 2008 to June 2011. All the patients had refused surgery or surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Yanli, Shan, Jinlu, Liu, Jia, Zhao, Kewei, Chen, Shu, Xu, Wenjing, Zhou, Qian, Yang, Mei, Lei, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240549/
https://www.ncbi.nlm.nih.gov/pubmed/28094790
http://dx.doi.org/10.1038/srep40619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240549/
https://www.ncbi.nlm.nih.gov/pubmed/28094790
http://dx.doi.org/10.1038/srep40619

Ejemplares similares